The role of Ketotofen in the treatment of postoperative ileus.

The role of Ketotofen, a mastcell stabilizer, in the treatment of postoperative ileus.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24494

Enrollment

Registered

2005-06-02

Start date

2004-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Ketotofen 4 mg or 12 mg or placebo per day.

Eligibility

Inclusion criteria

Inclusion criteria: Laparotomy for (malignant) proces originaty from colon or female reproduction organs.

Exclusion criteria

Exclusion criteria: Pre-operative radiation, intake of medication with effect on the Gastrointestinal motility, intake of immunosuppressiva, intake of anti-allergy medication, intra-abdominal inflammation (cholecystitis or absces included).

Design outcomes

Primary

Measure	Time frame
Gastric emptying.	—

Secondary

Measure	Time frame
Symptoms.	—

Contacts

Public ContactG.E.E. Boeckxstaens

Academic Medical Center (AMC), Department of Gastroenterology, C2-328, P.O. Box 22660

g.e.boeckxstaens@amc.uva.nl+31 (0)20 5667375

Outcome results